US 8926986
Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax
granted A61KA61K2039/521A61K2039/6081
Quick answer
US patent 8926986 (Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/521, A61K2039/6081, A61K39/00, A61K39/0208